Dec 10, 2025
Bridging Medicine, Economics, and Policy: An Interview on the Progress, Potential, and Possibilities Podcast
Dr. Amar Rewari joins host Ira S. Pastor to discuss the intersection of radiation oncology and health policy, the transition from investment banking to medicine, and the future of value-based care.
A Conversation on the Future of Radiation Oncology and Health Policy
Dr. Amar Rewari recently sat down with Ira S. Pastor, host of the Progress, Potential, and Possibilities podcast, for a wide-ranging discussion on the complexities of the modern healthcare system.
In this episode, Dr. Rewari shares his unique "non-linear" career path, detailing how his experience in investment banking at Credit Suisse and his dual MD/MBA from Yale helped shape his approach to clinical leadership. He discusses how early experiences studying abroad in Denmark and working in India’s healthcare system influenced his perspective on patient care and social policy.
Key topics covered in this episode include:
The Future of Treatment: Dr. Rewari breaks down 2026 trends in radiation oncology, including the rise of adaptive radiation therapy (ART), which allows clinicians to "re-plan" treatment on the fly as tumors shrink, and the increasing role of biomarkers and AI in personalized medicine.
The Economics of Healthcare: The conversation dives deep into the business side of medicine. Dr. Rewari explains the challenges of "budget neutrality" in Medicare reimbursement and advocates for the Radiation Oncology Case Rate (ROCR) model—a legislative effort to create stable, episodic-based payments that protect patient access to care.
Philanthropy and Education: Dr. Rewari also highlights his work as Chair of the Board for the Fund for Education Abroad, a nonprofit dedicated to increasing access to international education for underrepresented students.
Whether you are a clinician, a policy wonk, or simply interested in how medical technology and economics intersect, this episode offers a behind-the-scenes look at the decisions shaping the future of cancer care.




